A Phase 2 Trial for Patients With Metastatic Solid Cancer

Clinical trial NCT04713371 · UNKNOWN

Trial details

NCT number: NCT04713371
Sponsor: Rampart Health, L.L.C.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Cancer

Start date: 2021-05-19
Primary completion: 2024-12-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.